A B S T R A C T

Background
Upper tract transitional cell carcinomas (TCC) are uncommon and aggressive tumours. There are a number of surgical approaches to manage this condition including open radical nephroureterectomy and laparoscopic procedures.
Objectives
To determine the best surgical management option for upper tract transitional cell carcinoma.
Search methods
A sensitive search strategy was developed to identify relevant studies for inclusion in this review. The following databases were searched for randomised trials evaluating surgical approaches to the management of upper tract TCC: Medline EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL, British Nursing Index, AMED, LILACS, Web of Science®, Scopus, Biosis, TRIP, Biomed Central, Dissertation Abstracts, and ISI Proceedings.
Selection criteria
The following criteria that were considered for this review.
Types of studies -All randomised or quasi-randomised controlled trials comparing the various surgical methods and approaches for the management of localised upper tract transitional cell carcinoma.
Types of participants -All adult patients with localised transitional cell carcinoma. Localised disease was defined as limited to the kidney or ureter with no gross regional lymph nodal enlargement on imaging.
Types of interventions -Any surgical method or approach for managing localised upper tract transitional cell carcinoma.
Types of outcome measures -Overall and cancer-specific survival were primary outcomes. Surgery-related morbidity. Quality of life and health economics outcomes were secondary outcomes.
Data collection and analysis
Two review authors examined the search results independently to identify trials for inclusion.
Main results
We identified one randomised controlled trial that met our inclusion criteria. The trial showed that the laparoscopic approach had superior peri-operative outcomes compared to open approach. Laparoscopic was superior and statistically significant for blood loss (104 mL (millilitres) versus 430 mL, P < 0.001) and mean time to discharge (2.3 days versus 3.7, P < 0.001). Oncological outcomes (bladder tumour-free survival, metastasis-free survival, cancer-specific survival curves), at a median follow up of 44 months and in organ-confined disease, were comparable for both groups.
Authors' conclusions
There is no high quality evidence available from adequately controlled trials to determine the best surgical management of upper tract transitional cell carcinoma. However, one small randomised trial and observational data suggests that laparoscopic approach is associated with less blood loss and early recovery from surgery with similar cancer outcomes when compared to open approach.
P L A I N L A N G U A G E S U M M A R Y
Surgery for upper tract transitional cell carcinoma
Upper tract transitional cell carcinoma is an uncommon cancer mainly affecting the draining system of the kidney (kidney pelvis) and ureter (the tube through which urine passes from the kidney to the bladder). The main treatment approach for this condition is surgical removal of the malignant area. There are a number of surgical techniques for this procedure and the aim of this review was to compare them and determine which was the most effective in terms of surgical ease, patient morbidity, clinical outcome and cost. Our search of the literature found no high quality evidence comparing different surgical techniques. Evidence from one small randomised trial and observational studies suggests that laparoscopic surgical intervention may reduce blood loss, post-operative pain and hospital stay. However, the quality of the evidence is poor and, therefore, it is not possible to recommend the most effective surgical procedure to replace the existing clinical practice for managing upper tract transitional cell carcinoma.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
We performed a comprehensive search for randomised or quasi-randomised controlled trials that compared the pre-stated objectives. Only one randomised control trial comparing laparoscopic nephroureterectomy with open nephroureterectomy was identified (Simone 2009).This trial showed that the laparoscopic approach had superior peri-operative outcomes when compared with the open approach, which were statistically significant for blood loss (104 mL versus 430 mL; P <0.001) and mean time to discharge (2.3 days versus 3.65 days). The oncological outcome (bladder tumour free survival, metastasis free survival, cancer-specific survival curves) at a median follow-up of 44 months, in organ confined disease, were comparable for the two groups There were 22 comparative studies comparing various options of radical nephroureterectomy (open, laparoscopic) as shown in Table  4 . Whilst they all showed better early surgical outcomes in the laparoscopic group and comparable oncological outcomes, they were however excluded as they were all retrospective studies. Our search revealed 5 retrospective studies comparing various techniques (open, transurethral and laparoscopic) of dealing with distal end of the ureter. We found three comparative studies between nephron sparing surgery and nephroureterectomy and just one study comparing percutaneous management and nephroureterectomy. These comparisons were again retrospective and were therefore excluded from the study xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
B A C K G R O U N D
Upper tract transitional cell carcinomas (TCC) are uncommon and aggressive tumours. There are a number of surgical approaches to manage this condition including open radical nephroureterectomy and laparoscopic procedures. 
Description of the condition
Description of the intervention
Open nephroureterectomy (ONU) has been the standard surgical option for upper tract TCCs, with a normally functioning contra-lateral collecting system. The procedure consists of total nephroureterectomy, with excision of the bladder cuff around the ureteric orifices to prevent tumour recurrence in the ureteric stump or around the ipsilateral ureteric orifice. The procedure entails either two incisions or a single long incision for adequate exposure. As a result there is significant morbidity in the form post-operative pain and therefore prolonged hospitalisation (Rassweiler 2004). There has been considerable advancement in recent years, with the aim of reducing post-operative pain and hospital stay, in minimal invasive surgery. Some of the viable alternates include laparoscopic nephroureterectomy (LNU), ureteroscopic resection/fulguration, or percutaneous management. 
How the intervention might work
Surgical excision of upper tract transitional cell carcinoma is considered the standard of care. This can be achieved either by open or by the key-hole approach (laparoscopy). In addition, the removal of the ureter along with a cuff of bladder is considered an essential part of the procedure, and which may need a prior endoscopic incision or a second open surgical incision. There are some reports of pure endoscopic (retrograde or percutaneous) control of lowgrade upper tract transitional cell carcinoma in a selected population (Lee 1999).
Why it is important to do this review
Upper tract transitional cell carcinoma, although relatively rare as compared with other urological cancer, has a tendency for mul-tifocality and aggressive behaviour (local recurrences and metastases). The traditional and standard therapeutic approach of open nephroureterectomy has been challenged by various minimally invasive procedures, including laparoscopic surgery. Many techniques are being offered for dealing with this surgically challenging problem, and it is important that an up-to-date appraisal of literature, in the form of a systematic review, be undertaken to inform clinical practice.
O B J E C T I V E S
To determine the best surgical management of upper tract transitional cell carcinoma.
The following comparisons were pre-stated:
1. whether open radical nephroureterectomy is better than laparoscopic nephroureterectomy;
2. whether nephroureterectomy is better than conservative localised resection of ureter, where indicated;
3. whether open surgical resection (local or nephroureterectomy) is better than endoscopic resection and surveillance, where indicated;
4. whether open surgical method of handling the lower end of the ureter is better than endoscopic or laparoscopic assisted methods.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised or quasi-randomised controlled trials comparing the various surgical methods and approaches for the management of localised upper tract transitional cell carcinoma.
Types of participants
All adult patients with localised transitional cell carcinoma. Localised disease was defined as limited to the kidney or ureter, with no gross lymph nodal enlargement on imaging.
Types of interventions
Any surgical method or approach for managing localised transitional cell carcinoma of the upper urinary tract.
Types of outcome measures Primary outcomes
Overall and cancer-specific survival following surgical resection of upper tract TCC using different approaches.
Secondary outcomes
Early surgical outcome
Need for re-operation Operative complications Post-operative morbidity / mortality Length of operation Length of hospital stay Duration of catheterization Analgesic requirement Positive surgical margins (local resection of ureter)
Cancer outcome measures
Incidence of local recurrence or progression Incidence of distant metastasis
Health-related quality of life (HRQOL) outcome measures
Generic HRQOL measures (e.g. SF-36, Ware 1992) Disease-specific HRQOLmeasures (e.g.UCLA PCI, Litwin 1998)
Health economic outcome measures
Resource implications of differences in outcomes Resource implications of differences in impact on HRQOL Formal economic analysis (cost utility) Length of hospital stay (days) and associated costs (in GBP)
Search methods for identification of studies
A sensitive search strategy was developed to identify relevant studies for inclusion in this review. Specific search terms were used in conjunction with the Cochrane highly sensitive search strategy for RCTs as described in the Cochrane Handbook for Systematic Reviews of Interventions (designed in OVID version of MEDLINE) (Cochrane Handbook 2009). The terms used along with the dates for all the databases are described in 'Appendix 1'.
Data collection and analysis
A single randomised controlled trial was identified during the search strategy. This precludes any formal meta-analysis; hence a narrative approach was adopted to describe the study.
Selection of studies
A list of titles and abstracts of potentially relevant clinical studies were generated by the search strategy and imported in to a bibliographic software (EndNote®). This list was screened by two authors independently (BR and IE) and fully published papers (non abstracts) were retrieved where appropriate. These papers were further assessed to ensure they met the inclusion criteria of this review and data extraction.
Data extraction and management
Data was extracted from each identified paper independently by two reviewers and cross checked. The extracted data included information on trial design, participants, types of interventions, and outcome measures. Data analyses compared radical surgery with other primary surgical modalities and comparisons were made for each of the outcomes. Also, comparisons were made between different surgical approaches
Assessment of risk of bias in included studies
Trial quality was assessed according to the method of randomisation, allocation concealment, adequate descriptions of numbers, and reasons for patient withdrawal, as detailed in the Cochrane Handbook for Systematic Review of Interventions.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of excluded studies.
Results of the search
The results of the search strategies are summarised in ' Table  1 '. Of the 400 potentially relevant publications identified and screened for retrieval, just one randomised control trial comparing early surgical and oncological outcomes between laparoscopic nephroureterectomy and open nephroureterectomy was identified. The majority of the remaining studies were excluded, generally due to the lack of suitability of study design or intervention. Of the excluded studies thirty-one (Bariol 2004;
Included studies
Our review identified just one randomised control trial (Simone 2009) comparing laparoscopic nephroureterectomy with open nephroureterectomy that met inclusion criteria. Forty patients with non-metastatic upper tract TCC were randomised to open nephroureterectomy and 40 patients to the laparoscopic approach. Reported outcomes included operation times, the extent of blood loss, hospital stay, bladder tumour-free survival, metastatic-free survival and cancer-specific survival.
Excluded studies
A number of retrospective non-randomised studies making the comparison between the pre-stated objectives (' Table 2 There were five retrospective studies identified in our search that compared various techniques of en-bloc excision of the lower ureter (' Table 3 Table 4 ').
Risk of bias in included studies
The only randomised controlled trial included in this review used stratified permuted randomisation technique with ratio of 1:1 for treatment allocation. For risk of bias, see ' Figure 1 '.
Figure 1. Risk of bias graph: review authors' judgements about each risk of bias item presented as
percentages across all included studies. 6 
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Allocation
There was no allocation concealment in the single study included in this review. Consequently there was a high risk of reporting bias.
Blinding
No blinding of treatment allocation, intervention or outcome assessment was evident in the included trial.
Incomplete outcome data
Despite high stage and high grade tumours in ONU group, the LNU group has worse 5 year cancer specific survival rates and 5 year metastasis free survival rates (although not statistically significant). This hasn't been explained. The study does not give the absolute figures for bladder tumour free rates for the two groups.
Selective reporting
The study addressed relevant immediate and oncological outcomes.
Other potential sources of bias
The median follow up of this study was 41 months. Longer follow up will be required to establish true oncological outcomes. Forty patients with non-metastatic upper tract transitional cell carcinoma were recruited for both approaches. Peri-operative outcomes were compared using Student's t-test and oncological outcomes were compared using the log-rank test. Further analysis was performed after stratification by grade and stage. This trial showed that the laparoscopic approach had better statistically significant results for blood loss (104 mL versus 430 mL, P < 0.001) and mean time to discharge (2.30 days versus 3.65 days, p<0.001) when compared to the open approach. At a median follow up of 44 months, the overall 5 year cancer-specific survival ( 89.9% versus 79.8%) and 5 year metastasis-free survival rates (77.4% versus 72.5%) for the open approach were better than the laparoscopic approach, respectively, although not statistically significant.The bladder tumour free rates for the two groups were similar. However, on further stratification by stage and grade, the oncological outcomes for organ-confined disease (Stage < T3) were comparable for the two groups.
Effects of interventions
D I S C U S S I O N
Our search strategy included a comprehensive search of electronic databases, meticulous handsearching of relevant journal articles and abstracts and personal communication with experts in urooncology. Therefore, it is highly unlikely that important studies have been missed.
Our study found just one randomised control trial comparing laparoscopic nephroureterectomy with open nephroureterectomy (Simone 2009).This trial showed that the laparoscopic approach had better perioperative outcomes when compared with the open approach. There was statistically significant more blood loss (104 mL versus 430 mL; P < 0.001) and longer time to discharge (2.30 days versus 3.65 days) for open surgery compared to laparoscopic approach, respectively. The oncological outcomes (bladder tumour-free survival, metastases-free survival, cancer-specific survival ) at a median follow-up of 44 months, in pathologically confirmed organ-confined disease were comparable for the two groups.
We identified a number of observational studies comparing different surgical approaches to the management of TCC. However, we would strongly recommend caution in interpreting these results, given the various methodological problems with the retrospective study design, particularly the small sample sizes and their associated lack of power. This systematic review has highlighted the paucity of good quality RCTs for surgical management of upper tact transitional cell carcinoma. This is disappointing given that several surgical procedures (in particular minimally invasive procedures) have been introduced over the past two decades in clinical practice with reported patient-based outcomes. Observational data and one small randomised trial, despite the small sample sizes, indicate that that laparoscopic approach has better early surgical outcomes, and comparable oncological outcomes in the management of upper There are several documented problems in conducting a well designed randomised controlled trial for comparing surgical interventions. With the introduction of laparoscopic approach to the surgical excision of upper tract TCC with various reported advantages, at least in the in the case series and non-randomised liter-ature, patients preference becomes the main issue. This is a potential reason for failure to recruit enough numbers to answer the research question.The operator's choices or biases towards a particular procedure, which is dependent on the operator's skill and education, are the other impeding factors. Furthermore, blinding of outcome assessors to the surgical procedures, especially if they are compared, remains a subject of methodological discussion in the surgery.
Summary of main results
In patients with localised disease, the laparoscopic approach is associated with significantly less blood loss and hospital stay which translates into better recovery from the procedure. Short term follow-up data reports no significant differences in the oncological outcomes between laparoscopic and open approach. Clinically effectiveness of laparoscopic approach in patients with locally advanced disease (T3 and suspected nodal involvement) remains to be proven.
Overall completeness and applicability of evidence
In view of the poor quality of evidence, mainly from retrospective or non-controlled studies with poor design, applicability of results to the real clinical practice are difficult to justify. The technology in the laparoscopic approach has disseminated faster than than the evidence in the surgical practice and it is unlikely that results will change the current practice.
Quality of the evidence
The overall quality of available evidence identified by this review remains poor making it difficult to make a particular recommendation for change in surgical practice of upper tract TCC.
Potential biases in the review process
The main bulk of the literature on surgical approaches in upper tract TCC comes from uncontrolled (retrospective or prospective) studies with inherent risks of selection and reporting biases.
Agreements and disagreements with other studies or reviews
A recent non-systematic review reported that the laparoscopic approach was associated with a longer operating time (277 minutes versus 200 minutes), but reduced blood loss (241 mL versus 463 mL), a reduced analgesic requirement, and a shorter hospital stay, compared to open surgery (Rassweiler 2004). From an oncological perspective, there was no statistically significant differences between the two groups for bladder recurrence (24.0% versus 24.7%), local recurrence (4.4% versus 6.3%) and distant metastasis (15.5% versus 15.2%).The 2 and 5-year survival rates for the laparoscopic and open groups were 75.2% versus 76.2%, and 81.2% versus 61%, respectively (Rassweiler 2004). A recent multicentre retrospective study of 1249 patients with non metastatic upper tract transitional cell carcinoma compared the oncological efficacy, i.e. recurrence rate and cancer-specific mortality, between open and laparoscopic nephroureterectomy. The five-year recurrence free survival estimates were 86.8% and 76.2% for LNU and ONU, respectively. Five-year cancer-specific mortality-free survival estimates were 85.8% and 73.1% for LNU and ONU, respectively. The LNU cohort did, however, have more pathologically favourable cases. In a univariate adjusted analysis to stage and also an adjusted multivariate analysis, there was no statistical difference for recurrence and cancer specific mortality between ONU and LNU (Capitanio 2009).
A U T H O R S ' C O N C L U S I O N S
Implications for practice
Although voluminous literature exists comparing different surgical approaches for the management of upper tract TCC, the quality of the retrospective studies and the one small randomised controlled trial is poor. The conclusions of the reported literature support the early benefits (less blood loss and shorter hospital stay) of the laparoscopic approach, which is the current standard of practice in many centres around the world. This review cannot support any potential change in surgical practice of upper tract TCC due to inherent biases, poor quality of design, and reporting of the systematically reviewed studies.
Implications for research
The review has the following implications for research.
1. Future multicentre randomised controlled trials are required to assess the benefits and harms of one surgical approach over another in the management of upper tract TCC.
2.
A consensus is needed for outcomes reporting, standardisation of surgical technique, and introduction of newer procedures for a disease such as upper tract TCC, where multiple approaches have been shown to be feasible and effective.
3. Qualitative research in assessing the attitudes of patients and physicians towards changes in surgical practice. 4. Need for randomised controlled trials in surgical treatment.
5.
Research in surgical skills education and its influence on the outcomes of procedures.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Simone 2009
Methods RCT The median follow up in this study is 41 months. Longer follow up will be required to establish true oncological outcomes 
·
Recurrence free survival and disease specific survival similar for both groups Table 4 
. Studies comparing outcomes of nephron sparing surgery and radical nephroureterectomy
Study
Objectives Findings
Giannarini 2007 Distal ureter resection with bladder cuff excision and ureter re-implantation versus radical nephroureterectomy with bladder cuff excision
• Cancer specific survival at 5 and 10 years was not statistically significantly different (log-rank test, P = 0.896)
• Overall survival at 5 and 10 years was not statistically significantly different (log-rank test, P = 0.693) Dragicevic 2009 Open conservative surgery versus Radical nephroureterectomy
• 5 year survival rates 59% versus 55%
• 5 year survival rates for imperative and elective indications 41% versus 75%
• Radical nephroureterectomy had statistically significant poor outcomes for the disease on univariate analysis (HR = 2.2, 95% CI 1.1 to 4.6, P = 0.030)
Lucas 2008
Nephron sparing surgery versus nephroureterectomy Low grade disease
• ·5-year Overall survival 75.4% versus 66.4% P = 0.281
• ·5-year Disease Specific survival 86.2% versus 87.4% P = 0.909 High grade disease • ·5-year overall survival 45% versus 71.5% P = 0.077
• ·5-year disease-specific survival 68.6% versus 75% P = 0.528
